Rhythm Pharmaceuticals stockRYTM
Rhythm Pharmaceuticals trades at $105.02, 14.1% below its 52-week high (Dec 11, 2025). The price is above its 50- and 200-day averages, i.e. in an uptrend. −1.9% year to date, +5.6% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 3, 2027.
Ratings, candles, signals and the screener for RYTM — after you log in
Open the terminalFrequently asked questions about Rhythm Pharmaceuticals
What is the Rhythm Pharmaceuticals stock price?
At the close on Nov 5, 2026: $105.02 (−5.11% on the day). 52-week high: $122.20 on Dec 11, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Rhythm Pharmaceuticals report earnings?
The next quarterly report is on Mar 3, 2027. Last quarter, earnings per share changed +26% year over year, revenue +80%.
Does Rhythm Pharmaceuticals pay dividends?
No, Rhythm Pharmaceuticals does not pay dividends.
Where does Rhythm Pharmaceuticals trade and how to buy it?
Ticker RYTM, exchange Nasdaq, listed since 2017. You can buy it through a broker with access to US exchanges.
Should I buy Rhythm Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for RYTM are in the terminal after you log in.